Pricing Log in Create free account
Saturday 17 October 2026 Export ALGN’s income statement to Excel — free account

Align Technology, Inc.

ALGN Healthcare Medical Instruments & Supplies

Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024. In the quarter to June 2026, revenue grew 4.32%, EPS fell 12.2% and free cash flow grew 85.8%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

147.31 2.03 −1.36%
Market cap
$10.6B
P/E
25.6×
Fwd P/E
20.7×
Dividend yield
—
F-score
6/9
Altman Z
4.73
Beneish M
−2.52
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Align Technology, Inc. (ALGN) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Align Technology, Inc. (ALGN) trades at a EV/Sales of 2.3×. Over the past ten years it has ranged from 2.0× (September 2025) to 19.4× (February 2021); the current reading is higher than 2% of that period. That is below the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.5× (30.39%)
FY2024 3.6× (28.14%)
FY2023 5.1× 21.38%
FY2022 4.2× (67.43%)
FY2021 12.8× (22.92%)
FY2020 16.6× 88.05%
FY2019 8.8× 8.52%
FY2018 8.2× (30.43%)
FY2017 11.7× 78.18%
FY2016 6.6× 17.31%

Quarterly newest first

Period EV/Sales Change
Jun 2026 2.6× (3.08%)
Mar 2026 2.7× 7.68%
Dec 2025 2.5× 25.33%
Sep 2025 2.0× (37.51%)
42 more quarters

Against its own ten years

Low 2.0× High 19.4×
Ten-year median 6.4×
Current reading's percentile 3

EV/Sales against peers

Company EV/Sales
BAX Baxter International Inc. compare 1.8×
BLCO Bausch + Lomb Corporation compare 2.0×
AVTR Avantor, Inc. compare 2.2×
ALGN Align Technology, Inc. 2.3×
ATR AptarGroup, Inc. compare 2.3×
SOLV Solventum Corporation compare 2.4×
COO The Cooper Companies, Inc. compare 3.2×
TFX Teleflex Incorporated compare 3.6×
RGEN Repligen Corporation compare 12.3×
Medical Instruments & Supplies industry median 2.9×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ALGN